SCHEMBL21170636

SCHEMBL21170636

CN(C)CCCOc1cc(F)c(-c2c(N)nc(-c3ccccn3)nc2Cl)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
HTT P42858 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
PPP1CA P62136 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
FFAR1 O14842 7/20 0.41
ALDH1A1 P00352 1/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.39
CDK2 P24941 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
METAP1 P53582 2/20 0.36
METAP2 P50579 1/20 0.36
KDR P35968 1/20 0.36
F12 P00748 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15626284 0.83 FFAR1 (0.38) FFAR1ALDH1A1ATMMETAP1METAP2
SCHEMBL16989342 0.81 FFAR1 (0.36) NPC1L3MBTL1SMN1; SMN2FFAR1RAB9A
SCHEMBL15626286 0.81 FFAR1 (0.36) NPC1L3MBTL1SMN1; SMN2FFAR1RAB9A
SCHEMBL21170664 0.77 HRH3 (0.41) MAPTCYP1A2CYP2D6CYP19A1CYP2C9
SCHEMBL4016532 0.72 PAICS (0.37) CDK2
SCHEMBL4018558 0.72 LIMK1 (0.37) MAPT
SCHEMBL4016367 0.71 ESR1 (0.35) CDK2MAPTKDR
SCHEMBL4022147 0.71 METAP1 (0.51) NPC1HTTL3MBTL1PPP1CASMN1; SMN2
SCHEMBL4018429 0.70 ESR1 (0.35) KDR
SCHEMBL16989331 0.70 LIMK1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2903436-B1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEURODEGENERATIVE TAUOPATHIES UNIV PENNSYLVANIA (US) 2019-07-17 EP disclosed